Reports Q1 revenue $879M, consensus $853.91M. “In the first quarter, organic sales were roughly flat excluding the Byte sales impact, with growth in two of our three regions. Adjusted EBITDA margin expanded which primarily reflects the benefits from our transformational initiatives and internal financial discipline. We are delivering progress through customer-centric innovation, customer experience improvements, and operational efficiency, while operating in an increasingly uncertain macroeconomic environment,” said Simon Campion, President and Chief Executive Officer. “Looking forward, we are maintaining our outlook for organic sales and adjusted EPS and will continue to focus on improving what is within our control to deliver sustainable long-term performance.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- XRAY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Dentsply Sirona price target lowered to $16 from $20 at Piper Sandler
- Dentsply Sirona price target lowered to $16 from $18 at Mizuho
- Dentsply Sirona downgraded to Equal Weight at Morgan Stanley
- Dentsply Sirona downgraded to Equal Weight from Overweight at Morgan Stanley
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue